Credent Connect N Care Limited operates as a specialised integrated healthcare support ecosystem in India, delivering B2B pre-analytical services that include healthcare cold-chain logistics, doorstep home sample collection, on-site diagnostics staffing, and courier aggregation.
Find our updated IPO calendar with latest SME & Mainboard IPOs with updated data.
The Credent Connect N Care IPO, marking the enterprise's transition to the public markets, opens on August 13, 2026, and closes on August 17, 2026, with the company seeking to raise up to ₹94.00 crore through a fresh issue of 49,68,000 equity shares.
For this NSE SME offering, the issue price is set at ₹179–₹189 per equity share, with a minimum retail application size of 1,200 shares.
Inside this detailed review of the Credent Connect N Care IPO, we track essential details like the current price band, allotment schedule, subscription data, and today's premium rates.
Briefs of Credent Connect N Care IPO Details
- Price Band: ₹179 – ₹189 per share
- IPO Open / Close Dates: 13 August 2026 / 17 August 2026
- Lot Size: 600 shares (Minimum retail investment is 2 lots: 1,200 shares)
- Issue Size: 49,68,000 shares / Up to ₹94.00 crores
- Fresh Issue / OFS: Fresh Issue of 49,68,000 shares / OFS: Nil
- Registrar: KFin Technologies Ltd.
- Listing Exchange: NSE SME
IPO Reservation
- Face value: ₹10 per share
- Anchor offer: Up to 60% of the QIB Portion
- QIB-shares: Not more than 50% of the Net Issue
- NIIs-Shares offered: Not less than 15% of the Net Issue
- RIIs- Shares offered: Not less than 35% of the Net Issue
What is the Current Grey Market Premium (GMP) for the Credent Connect N Care IPO?
Check our main GMP page to stay updated on this IPO's premium along with other current issues.
These numbers respond daily to market demand and should be viewed strictly as an unofficial benchmark not governed by SEBI or the major exchanges.
Also check GMP Vs Listing Analysis of July's 34 IPOs.
What are the Key Dates Investors need to know regarding the Credent Connect N Care Allocation Process?
- IPO Open & Close Date: 13 August 2026 to 17 August 2026
- Basis of Allotment Date: 18 August 2026
- Refund Initiation Date: 19 August 2026
- Credit of Shares: 19 August 2026
- Listing Date: 20 August 2026
What are the Primary Objectives Behind the Credent Connect N Care IPO Capital Raise?
The company's leadership team plans to utilize the net proceeds from this offering to fund the following core initiatives:
- Subsidiary Investment: An allocation of ₹29.80 crores is earmarked for its wholly-owned subsidiary, Credent Healthcare Private Limited, to fund its working capital needs and procure clinical imaging machinery (sonography and digital X-ray machines).
- Working Capital Requirements: ₹37.00 crores will be directed toward funding the parent company's working capital, specifically to manage higher transaction volumes and stretched trade receivables.
- Debt Repayment: Approximately ₹6.00 crores will be utilised to prepay or repay outstanding credit facilities, aiming to lower finance costs.
- General Corporate Purposes: A maximum of 15% of the total gross proceeds, or up to ₹10.00 crores, will be allocated from the balance to handle everyday operational costs.
You can't miss this important iPO details IPO Listing Performance Tracker 2026 – Complete Dataset of IPO Listing Gains in India
How has Credent Connect N Care Performed Financially in Recent Fiscal Periods?
The following section outlines the key financial records of the company, with all figures stated in Rupees Crores. (Note: FY26 is reported on a consolidated basis, while FY25 and FY24 are on a standalone basis).
Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
Total Income | 214.43 | 78.23 | 76.02 |
Profit After Tax | 18.45 | 2.25 | 2.66 |
EBITDA | 28.46 | 4.99 | 4.30 |
Total Borrowing | 21.95 | 7.42 | 6.85 |
Assets | 81.57 | 29.50 | 26.41 |
Financial Observations
Total Income
The company registered a highly aggressive upward trajectory in its revenue streams over the observed fiscal periods.
- Total income expanded massively from ₹78.23 crores in FY25 (Standalone) to ₹214.43 crores in FY26 (Consolidated).
- This surge was primarily propelled by the strategic acquisition and consolidation of three wholly-owned subsidiaries.
- Deep integration within India’s fast-expanding healthcare diagnostics infrastructure further fueled this top-line scale-up.
Credent Connect N Care’s total income surged to ₹214.43 Cr in FY26 from ₹78.23 Cr in FY25, marking a 174% YoY increase.
Profit After Tax
Net profitability experienced exceptional multi-fold growth as operational capabilities matured and the corporate structure expanded.
- PAT surged dramatically from ₹2.25 crores in FY25 to ₹18.45 crores in FY26.
- The PAT margin improved noticeably, reaching 8.61% in the latest consolidated fiscal year.
- The high-margin contributions from subsidiaries, particularly Credent Healthcare, aided this bottom-line momentum.
Profit After Tax jumped to ₹18.45 Cr in FY26 from ₹2.25 Cr in FY25, an impressive 720% YoY increase.
EBITDA
Core operational earnings advanced significantly, reflecting the firm's improved tech-integrated efficiencies.
- EBITDA jumped from ₹4.99 crores in FY25 to ₹28.46 crores in FY26.
- The EBITDA margin widened to a competitive 13.29% during the most recent fiscal period.
- Proprietary technologies like LogiTrak optimised field productivity and fleet routing, enhancing overall margin retention.
EBITDA rose sharply to ₹28.46 Cr in FY26 from ₹4.99 Cr in FY25, a 470% YoY increase.
Total Borrowing
The business utilised external debt to manage its working capital-intensive logistics operations and acquisitions.
- Total borrowings more than doubled from ₹7.42 crores in FY25 to ₹21.95 crores in FY26.
- These funds were largely deployed to bridge the liquidity gap caused by an expanding geographic footprint.
- A dedicated portion of the fresh IPO proceeds is allocated to reducing this outstanding short and long-term debt burden.
Total borrowings increased to ₹21.95 Cr in FY26 from ₹7.42 Cr in FY25, a 196% YoY rise.
Assets
The overall resource base of the company widened to accommodate its rapidly scaling B2B service operations.
- Total assets expanded rapidly from ₹29.50 crores in FY25 to ₹81.57 crores in FY26.
- This build-up is heavily tied to current assets, specifically ₹58.83 crores in trade receivables.
- Goodwill on consolidation and capital work-in-progress further enlarged this physical asset base post-acquisitions.
What Are the P/E ratio and Peer Comparison of Credent Connect N Care Limited ?
Credent Connect N Care's P/E valuation reaches 13.55x at the upper price boundary of ₹189, evaluated against its current FY26 consolidated basic EPS of 13.95.
Analysis:
According to the Red Herring Prospectus, there are no listed companies in India engaged in a business similar to that of Credent Connect N Care (integrated pre-analytical cold-chain logistics and diagnostic staffing).
Therefore, a direct peer comparison is not applicable.
At the upper price band of ₹189, the company enters the primary market demanding an implied P/E multiple of approximately 13.55x.
Operating as a pure-play pioneer in this specific niche, the firm reports an exceptionally robust Return on Net Worth (RoNW) of 42.13% for FY26. This superior return metric underscores the company's highly efficient capital utilisation and strong profitability within its specific operational scale, potentially allowing it to command a scarcity premium.
What is The Industry Outlook of Credent Connect N Care Limited ?
Growth potential
- The Indian diagnostic lab sector is projected to double from USD 16.50 billion in FY25 to USD 31.50 billion by FY30, creating massive structural demand for specialized cold-chain logistics.
- The shift towards preventive healthcare and doorstep home sample collection provides a long-term volume runway for B2B pre-analytical service providers.
- Organised hospital chains and diagnostic centres are increasingly outsourcing their logistics and phlebotomist staffing to ensure compliance and reduce fixed overhead costs.
Market trends
- The pre-analytical healthcare logistics space requires stringent temperature-controlled infrastructure, establishing steep barriers to entry for unorganised courier players.
- Technology integration, such as real-time tracking platforms for sample viability, is becoming a mandatory requirement to secure long-term contracts with institutional health networks.
- High attrition rates among field personnel (phlebotomists and paramedics) remain a persistent operational challenge, requiring continuous investment in recruitment and training.
What Are The Strengths and Risks of Credent Connect N Care IPO ?
Strengths:
- Integrated Platform: Operating a comprehensive pre-analytical support platform combining logistics with workforce solutions makes the service highly sticky for institutional clients.
- Inorganic Growth Synergies: The recent acquisition of three wholly-owned subsidiaries significantly enlarged the group's operational footprint, capabilities, and consolidated revenues.
- Superior Return Metrics: The business generates an exceptional Return on Net Worth (RoNW) of 42.13%, drastically reflecting strong capital efficiency.
Risks:
- Customer Concentration: The company is heavily reliant on a small group of institutional clients. The top 10 customers contributed 81.76% of operational revenues in FY26.
- Negative Cash Flows: Despite recording strong net profits, the company generated negative Cash Flow from Operations of ₹(6.62) crores in FY26, highlighting working capital intensity.
- Trade Receivable Strain: Trade receivables surged to ₹58.83 crores in FY26, representing 93.3% of all current assets, pointing to liquidity risks if clients delay payments.
Important IPO Related links
1. Upcoming & Live IPOs in India
2. IPO Allotment Status – How to Check Allotment Status of IPO Shares
3. Daywise IPO Subscription Status Today
5. July 2026 IPO Subscription Review: 32 IPOs Data, Demand Patterns & Key Trends
6. July 2026 IPO Review: 33 IPOs, ₹21140.52 Cr Raised & 56.37x Average Subscription
7. IPO Glossary: 100+ Important Terms Every Investor Should Know
Key Considerations for Investors
- Financial Restructuring: FY26 is reported on a consolidated basis due to three acquisitions, drastically inflating revenues (₹214.43 crores) and PAT compared to the standalone FY25 figures.
- Working Capital Strain: The business is heavily working-capital intensive, leading to negative operating cash flows of ₹(6.62) crores in FY26 and massive trade receivables (₹58.83 crores).
- Customer Dependency: Operations rely almost entirely on a concentrated client pool, with the top 10 customers accounting for 81.76% of FY26 revenues.
- High Return Metrics: Despite cash flow pressures, the consolidated entity operates highly efficiently, yielding an EBITDA margin of 13.29% and a stellar 42.13% RoNW.
Key Takeaways
- IPO Price Band: ₹179 to ₹189 per equity share
- Lot Size: 600 shares (Minimum retail application of ₹2,26,800 for 2 lots)
- Allotment Date: Allotment on 18 August 2026
- Listing Dates: Listing on NSE SME on 20 August 2026
FAQs on Credent Connect N Care IPO
For real-time premium updates on this SME offering, please refer to our centralized GMP dashboard. Keep in mind that these unofficial benchmarks shift daily alongside changing market trends and investor sentiment.
The application price range has been fixed at ₹179 to ₹189 per equity share.
Credent Connect N Care offers a unique "first-mover" opportunity in India's rapidly expanding pre-analytical healthcare logistics and support services sector. While strategic subsidiary acquisitions have scaled consolidated top-line growth and pushed EBITDA margins to a strong 13.29%, stock pickers must heed serious balance-sheet red flags. Heavy client concentration, negative operating cash flows, and stretched trade receivables of ₹5,882.73 lakhs present significant working capital risks.
Share allocations for this issue are expected to be officially determined and finalised on August 18, 2026.
After the share basis is settled, applicants can verify their allotment status through KFin Technologies Ltd. (the issue registrar) or directly on the NSE Emerge status checking page.
Credent Connect N Care proposes to list its equity shares on the NSE SME segment on August 20, 2026.
Disclaimer: This overview is intended solely for educational analysis and should not be treated as professional financial counsel. Always seek validation from a SEBI-certified advisor before investing your funds.
